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Highly potent but structurally simple transmembrane anion transporters are reported that function at
receptor to lipid ratios as low as 1 : 1 000 000. The compounds, based on the simple ortho
phenylenediamine based bisurea scaﬀold, have been studied for their ability to facilitate chloride/
nitrate and chloride/bicarbonate antiport, and HCl symport processes using a combination of ion
selective electrode and ﬂuorescence techniques. In addition, the transmembrane transport of
dicarboxylate anions (maleate and fumarate) by the compounds was examined. Molecular dynamics
simulations showed that these compounds permeate the membrane more easily than other promising
receptors corroborating the experimental eﬄux data. Moreover, cell based assays revealed that the
majority of the compounds showed cytotoxicity in cancer cells, which may be linked to their ability to
function as ion transporters.Introduction
The regulation of cellular ion concentration by complex
membrane spanning proteins is critical for a range of biological
processes.1 Misregulation of chloride transport has been asso-
ciated with myotonia, nephrolithiasis (kidney stones), Bartter’s
syndrome and cystic brosis.2 Similarly, bicarbonate transport
misregulation is linked to a range of disease states,3 and has
been linked with pathogenic mucus production in cysticthampton, SO17 1BJ, UK. E mail: philip.
nic Chemistry Department, University of
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s. Membrane transport experimental
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other electronic format see DOI:
: C57H72N14O15, M ¼ 1193.29, triclinic,
19(3) A˚, a ¼ 86.271(8), b ¼ 81.687(8),
0(2) K, P 1, Z ¼ 2, 33949 reections
R1 ¼ 0.0618 [F2 > 2s(F2)], R1 ¼ 0.0780
two negative charges of the carbonate
molecules. The two half molecules lie
ng thermal parameter and geometrical
Chemistry 2013brosis.4 By synthesising molecules that can facilitate the
transmembrane transport of chloride and bicarbonate it may be
possible to develop new treatments for this type of disease.
Furthermore, compounds that can facilitate H+/Cl symport or
Cl/HCO3
 antiport processes may function as anticancer
agents since the deacidication of acidic organelles leads to
cytoplasmic acidication, an early event in apoptosis.5 Indeed,
there are a number of anticancer agents that have been reported
to modulate intracellular pH. The prodiginines are one
example, with the anticancer activity of these molecules linked
to their ability to facilitate both H+/Cl symport and Cl/HCO3

antiport processes.6
The synthesis of small molecules that function as membrane
resident, mobile carriers for anions is an expanding eld of
research. By incorporating hydrogen-bond donor groups into a
suitably lipophilic scaﬀold it is possible to transport anions
through the hydrophobic interior of a lipid bilayer. Recent
examples of such scaﬀolds include the steroid-based chola-
pods,7 calix[4]pyrrole and its uorinated or triazole-strapped
analogues,8 amphiphilic catechols and monoacylglycerols,9
preorganised isophthalamides and squaramides,10 and tripodal
tris(aminoethyl)amine (tren) thioureas.11
Interest in this area has grown to encompass transporters
(carriers or otherwise) that show activity in biological
systems.6,12 To improve the likelihood of new transmembrane
transporter motifs exhibiting biological activity it is important
to design compounds that have suitable absorption, distribu-
tion, metabolism, excretion and toxicity (ADMET) characteris-
tics.13 There are guidelines, such as Lipinski’s rule of ve, thatChem. Sci., 2013, 4, 103 117 | 103
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View Article Onlinespecify ranges of ‘ideal’molecular properties such as molecular
weight, partition coeﬃcient and the number of hydrogen bond
donors and acceptors.14 By considering these guidelines we
generated transporters that exhibit biological activity in vivo,
such as uorinated molecules based on indolylurea/thiourea15
scaﬀolds that show promise as anticancer agents. By synthe-
sising transporters that obey the rules of thumb dened by
Lipinski and others, the possibility that these compounds will
be biologically compatible is greater, i.e. have acceptable
absorption, distribution, metabolism and excretion properties.
We have previously shown that bisurea receptors in which
the two urea groups are linked by alkyl chains can promote
chloride transport across phospholipid bilayers.16 In other work
we have shown that ortho-phenylenediamine-based bisureas are
eﬀective anion receptors.17 We decided to explore the anion
transport properties of ortho-phenylenediamine-based bisureas
as promising candidates for biologically active ion transporters
that may conform to the rules of thumb dened by Lipinski and
others.14
Molecules developed from this scaﬀold have found extensive
use in the eld of anion complexation; we have previously
reported that ortho-phenylenediamine-based bisureas function
as selective carboxylate complexation agents,17 whilst the anal-
ogous 4,5-dimethyl-1,2-phenylenediamine scaﬀold has been
used to construct colorimetric anion sensors.18 These motifs
can be extended with additional hydrogen bond donor groups
to yield receptors with enhanced anion aﬃnity.19 Trisureas and
tetraureas developed in this way show good selectivity for
phosphate and sulfate,20 whilst a tripodal tren-based hexylurea
functions as a sulfate extractant.21 Extended amidourea mac-
rocycles based on these scaﬀolds exhibit good selectivity
towards carboxylates.22 Replacement of the phenylene core with
anthraquinone yields colorimetric sensors for the detection of
Hg2+ and H2PO4
,23 whilst replacement with a cyclohexyl core
has been used for the chiral recognition of phosphate ions24 and
the colorimetric sensing of cyanide.25 Further, these molecules
have found other applications in crystal engineering,26 as gela-
tors,27 and in catalysis.28
In this paper we report the transmembrane transport
properties of ortho-phenylenediamine-based bisureas 1–8, and
compare them to monoureas 9–11; the latter being analogues
of the three most active bisurea transporters. The anion
binding properties of this series of compounds were deter-
mined using 1H NMR titration techniques in DMSO-d6/0.5%
H2O mixtures. Anion transport was studied using a combina-
tion of ion selective electrode assays and uorescence tech-
niques in phospholipid vesicles. In vitro viability and
uorescence assays have been performed in order to evaluate
the anticancer properties of these compounds. We show that
this hydrogen bonding array is a highly potent anion transport
motif with the most active compound studied showing trans-
port at 1 : 1 000 000 receptor : lipid ratios. Eﬀective transport
at very low concentrations is a desirable feature allowing the
potential use of these compounds in biological systems at low
dose. Finally, in silico studies were also performed to bring
further insights into the interactions of 5 and 6 with a lipid
bilayer model.104 | Chem. Sci., 2013, 4, 103 117Results and discussion
Synthesis
We have previously reported the synthesis of compounds 1,17a
3,17b 6,17b and 8.17b Reaction of the appropriate isocyanate with
ortho-phenylenediamine in dichloromethane/pyridine gave
compounds 4, 5 and 7 in 39%, 84% and 82% yields respectively.
Compound 2 was prepared by a similar method, using
4,5-diuoro-2-nitroaniline as the starting material. Hydrogena-
tion using Pd/C in methanol, followed by reaction with
phenylisocyanate in dichloromethane/pyridine yielded
compound 2 in 37% yield.
The syntheses of monoureas 9,29 10,30 and 11 (ref. 31) have
been previously reported.32 In all cases aniline was added to the
corresponding isocyanate in dichloromethane/pyridine to
produce compounds 9, 10, and 11 in 56%, 58% and 75% yields
respectively. These compounds are analogues of the three most
active bisurea transporters 4, 5 and 6.
Anion binding in solution
The ability of compounds 1–11 to bind anions in solution was
investigated using 1H NMR titration techniques in DMSO-d6/
0.5% water (with the anions added as tetrabutylammonium
(TBA) or tetraethylammonium (TEA) salts) both to provide
comparability with earlier studies33 and for solubility reasons.
The binding studies were performed for anions relevant to both
our transmembrane transport assays and biological systems.
Where possible the change in chemical shi of the most
downeld NH signal was tted to a 1 : 1 binding model using
WinEQNMR2 soware.34 The results are summarised in Table 1.
Previously reported stability constants are included for
comparison.17 Fitted curves and selected Job plots can be found
in the ESI.†
In general, compounds 1–11 exhibit strong 1 : 1 binding with
tetraethylammonium bicarbonate, moderate 1 : 1 binding with
tetrabutylammonium chloride and no signicant interaction
with tetrabutylammonium nitrate under the conditions of theThis journal is ª The Royal Society of Chemistry 2013
Table 1 Stability constants Ka (M
1) for compounds 1 11 with chloride and
nitrate (added as tetrabutylammonium salts) and bicarbonate (added as tetrae
thylammonium salt) in DMSO d6/0.5% water at 298 K
a
Chloride Bicarbonate Nitrate
1 (ref. 17a) 43 1370 b
2 73 c,d b
3 (ref. 17b) 67 2570d b
4 74 e b
5 78 2090d b
6 (ref. 17b) 78 3770d,f b
7 81 3140d,f b
8 (ref. 17b) <10 826e b
9 41 2580 b
10 61 1380 b
11 57 1630d,f b
a All errors <15%. Data tted to a 1 : 1 binding model. Binding constant
obtained by following the most downeld urea NH unless stated
otherwise. b No signicant interaction observed. c Sigmoidal curve
could not be tted to a suitable binding model. d Signicant
broadening of urea NHs observed. e Reliable binding constant could
not be obtained due to signicant broadening of urea NHs and
signicant overlap of aromatic CHs. f Dramatic colour change
observed upon addition of bicarbonate.
Fig. 1 X ray crystal structure of 7 (tetraethylammonium carbonate complex).
Counterions are omitted for clarity.
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View Article OnlineNMR experiments. A sigmoidal binding curve was obtained for
compound 2 with tetraethylammonium bicarbonate that could
not be tted to a binding model.35 Job plot analysis suggested
1 : 1 binding, however the plot was an unusual shape, that may
be due to more complex solution phase behaviour such as
deprotonation of the bound oxoanion.33b Signicant urea NH
peak broadening was observed upon addition of tetraethy-
lammonium bicarbonate to compounds 2, 3, 4, 5, 6, 7, 8 and 11.
A stability constant could not be determined for compound 4
with tetraethylammonium bicarbonate due to this broadening
eﬀect, however Job plot analysis conrmed 1 : 1 binding.
Comparing functionalised receptors 2–7 with receptor 1, it
can be observed that addition of electron withdrawing substit-
uents to either the central core or the peripheral phenyl groups
increases anion aﬃnity. In addition, it has been suggested that
halogenation of the phenylene core (2 and 3) can aid receptor
preorganisation by increasing the acidity of the phenylene CH
groups, strengthening intramolecular hydrogen bonding inter-
actions.17b For compounds 2–7 the binding constants obtained
with tetrabutylammonium chloride are of similar magnitude
whilst no signicant interaction was previously reported
between compound 8 and tetrabutylammonium chloride.17b
This lack of interaction was attributed to intramolecular
hydrogen bonding. The ortho-nitro groups may also provide a
steric constraint on the binding site. Similarly, compound 8 has
a signicantly lower binding constant with tetraethylammo-
nium bicarbonate than compounds 6 and 7.
Colour changes were observed upon addition of tetraethy-
lammonium bicarbonate to nitro-functionalised compounds 6,
7, 8 and 11. Such behaviour has been reported previously in the
presence of basic anions and has been attributed to deproto-
nation in analogous systems.17b,18,25,36
Interestingly, the two least active ion transporters (1 and 8)
display the lowest aﬃnity for both chloride and bicarbonate.This journal is ª The Royal Society of Chemistry 2013The most active transporter 6 has the highest aﬃnity of the
series for bicarbonate. In addition, the monourea compounds
9, 10 and 11 show reduced anion aﬃnity compared to their
bisurea analogues, demonstrating the impact of incorporating
additional convergent hydrogen bond donor groups into the
receptor scaﬀold.
To complement the transport studies, we attempted to titrate
compounds 4, 5 and 6 with tetrabutylammonium maleate and
tetrabutylammonium fumarate in DMSO-d6/0.5% H2O.37 Addi-
tion of the tetrabutylammonium dicarboxylate to the receptor
solution resulted in the formation of a precipitate in both
instances, preventing determination of a binding constant.
Instead ESI mass spectrometry was used to examine the inter-
action between bisureas and dicarboxylate anions. Compound 5
was studied owing to both its good solubility and high transport
activity. Negative ESI experiments with solutions of 5 and either
maleic or fumaric acid revealed the formation of 1 : 1 bisurea–
carboxylate complexes in the gas phase. Further, by analysing
samples containing diﬀerent ratios of bisurea host and
carboxylate anion it was possible to determine that compound 5
binds maleate more strongly than fumarate.38,39Solid state
The solid-state behaviour of compound 7 was examined using
single-crystal X-ray diﬀraction (Fig. 1). Tables of hydrogen
bonds, data collection and renement details, and thermal
ellipsoid plots can be found in the ESI.†
Crystals were obtained by slow evaporation of a methanol–
water solution of compound 7 in the presence of tetraethy-
lammonium bicarbonate. Analysis revealed that the meta-nitro
functionalised bisurea forms a 2 : 1 (receptor : anion) complex
with carbonate, the encapsulated carbonate anion bound by
eleven hydrogen-bonding interactions. All the available urea NH
groups were found to be involved in hydrogen bonding the
carbonate (N–O distances 2.726(2)–3.368(2) A˚, N–H/O angles
139.0–166.9). It appears that in the solid state the meta-nitro
group does not hinder guest inclusion.Chem. Sci., 2013, 4, 103 117 | 105
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View Article OnlineTransport studies
We assessed the ability of compounds 1–11 to transport anions
across phospholipid bilayers using a combination of ion
selective electrode and uorescence techniques. In a typical
assay unilamellar, 1-palmitoyl-2-oleoylphosphatidyl-choline
(POPC) vesicles (200 nm diameter) were prepared containing
sodium chloride (488 mM with 5 mM phosphate buﬀer at pH
7.2) and suspended in a solution of sodium nitrate (488 mM
with 5mMphosphate buﬀer at pH 7.2).40 Compounds 1–11were
added as solutions in DMSO and the resulting chloride eﬄux
from vesicles monitored using a chloride selective electrode
(Accumet). At the end of the experiment detergent (octaethylene
glycol monododecyl ether) was added to lyse the vesicles. The
nal reading was used to calibrate the electrode to 100% chlo-
ride release.
In these assays ion transport occurs by a passive process. To
maintain charge balance, ion transport must occur by either a
symport or an antiport mechanism.40 The chloride eﬄux in
Fig. 2 could therefore be a consequence of chloride/nitrate
antiport, chloride/sodium symport or HCl symport processes.
To examine the possibility of sodium/chloride co-transport,
an ISE assay was performed using vesicles containing caesiumFig. 2 Chloride eﬄux promoted by a DMSO solution of compounds 1 11 (2 mol
% carrier to lipid) from unilamellar POPC vesicles loaded with 488 mM NaCl
buﬀered to pH 7.2 with 5 mM sodium phosphate salts. The vesicles were
dispersed in 488 mM NaNO3 buﬀered to pH 7.2 with 5 mM sodium phosphate
salts. At the end of the experiment detergent was added to lyse the vesicles and
calibrate the ISE to 100% chloride eﬄux. Each point represents an average of
three trials. DMSO was used as a control. See Fig. S44 and S45† for versions of this
ﬁgure with error bars.
106 | Chem. Sci., 2013, 4, 103 117chloride buﬀered to pH 7.2 with 5 mM phosphate buﬀer. The
vesicles were suspended in a solution of sodium nitrate buﬀ-
ered to pH 7.2 with 5 mM phosphate buﬀer. In the event of
metal chloride co-transport we would expect the rate of chloride
release to be dependent on the nature of the metal cation.8,41
The rates of chloride release for vesicles containing sodium
chloride were within error of those observed for vesicles con-
taining caesium chloride, implying that metal/chloride symport
is not facilitated by these compounds (see ESI† for comparative
plots).
Chloride/bicarbonate antiport is a biologically signicant
process.3,6e,42 Compounds 1–11 were tested for ability to facili-
tate chloride exchange using a chloride selective electrode assay
with vesicles containing sodium chloride (451 mM with 20 mM
phosphate buﬀer at pH 7.2) suspended in a solution of sodium
sulphate (150 mM with 20 mM phosphate buﬀer at pH 7.2).
Compounds 1–11 were added as solutions in DMSO. Aer two
minutes a sodium bicarbonate ‘pulse’ was added such that the
external concentration of bicarbonate was 40 mM.
The external sulfate is more challenging to transport through a
lipid bilayer than bicarbonate, due to its higher hydrophilicity.43Fig. 3 Chloride eﬄux promoted by a DMSO solution of compounds 1 12 (2 mol
% carrier to lipid) from unilamellar POPC vesicles loaded with 451 mM NaCl
buﬀered to pH 7.2 with 20 mM sodium phosphate salts. The vesicles were
dispersed in 150 mM Na2SO4 buﬀered to pH 7.2 with 20 mM sodium phosphate
salts. At t ¼ 120 s a solution of sodium bicarbonate was added such that the
external concentration of bicarbonate was 40 mM. At the end of the experiment,
detergent was added to lyse the vesicles and calibrate the ISE to 100% chloride
eﬄux. Each point represents an average of three trials. DMSO was used as a
control. See Fig. S57 and S58† for versions of this ﬁgure with error bars.
This journal is ª The Royal Society of Chemistry 2013
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View Article OnlineConsequently, chloride eﬄux observed in the rst two minutes of
the assay (before the bicarbonate ‘pulse’) is not expected to be the
result of an anion antiport mechanism. Upon addition of the
‘bicarbonate pulse’ a chloride/bicarbonate antiport mechanism
becomes possible. A marked increase in transport activity was
observed for compounds 2–7 at this point (Fig. 3).
Low levels of chloride eﬄux were observed for some of the
compounds in the two minutes before the bicarbonate pulse in
the aforementioned assay. To investigate this eﬀect further, the
experiment was repeated without the bicarbonate ‘pulse’.
Signicant chloride eﬄux was observed for some of the
compounds (see ESI, Fig. S59†).
Evidence in support of transmembrane sulfate transport has
been observed previously for uorinated tripodal ureas and
thioureas.44 To test if the chloride eﬄux observed in the afore-
mentioned assay was linked to the transport of sulfate, uni-
lamellar POPC vesicles were prepared containing 100 mM NaCl
and 2 mM lucigenin buﬀered to pH 7.2 with 20 mM phosphate
buﬀer. These vesicles were suspended in 100 mM NaCl solution
buﬀered to pH 7.2 with 20 mM phosphate salts. A solution of
sodium sulfate was added such that the external concentration
of sulfate was 40 mM, and aer one minute compounds 2–7
were added as solutions in methanol (2 mol% carrier to lipid).
No evidence of sulfate transport was observed using this assay
(see ESI†).
Compound 6 facilitated the highest chloride eﬄux in the
sulfate ‘blank’ assay and was used to explore the possibility of
HCl co-transport using a pH gradient assay.45 Vesicles con-
taining 451mM sodium chloride buﬀered to pH 4.0 with 20 mM
citric acid buﬀer were suspended in a solution of 150 mM
sodium sulfate buﬀered to pH 7.2 with 20 mM sodium phos-
phate salts. Fig. 4 shows that the rate of chloride transport
facilitated by compound 6 under gradient conditions is greater
than in the absence of a pH gradient, implying that this mole-
cule can facilitate HCl symport in addition to anion–anion
antiport.Fig. 4 Chloride eﬄux promoted by a DMSO solution of compound 6 (2 mol%
carrier to lipid) from unilamellar POPC vesicles loaded with either 451 mM NaCl
buﬀered to pH 7.2 with 20 mM sodium phosphate salts or 451 mMNaCl buﬀered
to pH 4.0 with 20 mM sodium citrate salts. The vesicles were dispersed in 150 mM
Na2SO4 buﬀered to pH 7.2 with 20 mM sodium phosphate salts. At the end of the
experiment, detergent was added to lyse the vesicles and calibrate the ISE to
100% chloride eﬄux. Each point represents an average of three trials. DMSO was
used as a control.
This journal is ª The Royal Society of Chemistry 2013Proton transport was conrmed using POPC vesicles loaded
with NaCl (488 mM) and 1 mM 8-hydroxy-1,3,6-pyrenetrisulfo-
nate (HPTS), a pH sensitive uorescent dye.46 These vesicles
were suspended in a solution of Na2SO4 (150 mM) and the HPTS
uorescence measured upon addition of a DMSO solution of
compound 6. An increase in intravesicular pH was observed,
corresponding to deacidication of the vesicles via either
H+/Cl co-transport or an equivalent Cl/OH antiport pathway
(see ESI†).
Three modes of operation are known for synthetic trans-
membrane ion transporters; a mobile carrier mechanism,
channel formation, or a relay mechanism.47 We probed the
transport mechanism of these systems using an ion selective
electrode assay with POPC vesicles containing cholesterol (7 : 3
molar ratio). The vesicles were prepared containing sodium
chloride (488 mM with 5 mM phosphate buﬀer at pH 7.2) and
suspended in a solution of sodium nitrate (488 mM with 5 mM
phosphate buﬀer at pH 7.2). By comparing the chloride eﬄux
observed in this assay with that observed in the absence of
cholesterol we can deduce if these molecules are mobile
carriers. Cholesterol decreases membrane uidity and thus
transport that relies on a diﬀusion mechanism (i.e. mobile
carrier), is expected to be slower in the presence of cholesterol.48
Compounds 2–7 all showed reduced chloride eﬄux in the
cholesterol containing vesicles (see ESI†).
Further evidence for a carrier mechanism was obtained from
U-tube experiments.15,44 A membrane is modelled by two
aqueous phases separated by a nitrobenzene organic phase. The
source phase was loaded with sodium chloride (488 mM buﬀ-
ered to pH 7.2 with 5 mM sodium phosphate salts) and the
receiving phase was loaded with sodium nitrate (488 mM
buﬀered to pH 7.2 with 5 mM sodium phosphate salts). The
carrier (1 mM) was dissolved in the nitrobenzene phase and
chloride transport into the receiving phase was monitored
using an ion selective electrode. The separation of the two
aqueous phases rules out the possibility of channel formation.49
For solubility reasons only compounds 2, 4, 5 and 7 could be
tested in this way. All yielded a higher concentration of chloride
in the receiving phase than in the control (see ESI†). These
results are further evidence that the compounds operate via a
mobile carrier mechanism.
To quantify the transport activity of compounds 1–11 Hill
analyses50 for the chloride/nitrate and chloride/bicarbonate
antiport assays were performed (see ESI†). Hill analysis enables
determination of an EC50,270s value; the concentration of carrier
(mol% with respect to lipid) required to aﬀord 50% chloride
eﬄux 270 s aer addition of the carrier (or aer the bicarbonate
‘pulse’), enabling us to compare the transport activity of the
compounds. These values are summarised in Table 2, together
with the Hill coeﬃcients (which provide supporting evidence
for a mobile carrier mechanism), the calculated values for polar
surface area (PSA) and total surface area (TSA) and log P.51 The
PSA and TSA parameters were estimated as described in the
ESI† frommolecular dynamic (MD) simulations carried out with
compounds 1–11 in water solution.
In general, we observed that incorporation of electron with-
drawing functionalities into the bisurea scaﬀold aﬀordsChem. Sci., 2013, 4, 103 117 | 107
Table 2 Overview of transport assays, lipophilicity, PSA and TSA (average  SD) of compounds 1 11
clogPa PSAb (A˚2) TSAc (A˚2) EC50,270s
d (Cl /NO3 ) n
e (Cl /NO3 ) EC50,270s
d (Cl /HCO3 ) n
e (Cl /HCO3 )
1 4.97 89.9  7.1 482.7  18.0 na na na na
2f 5.80 155.5  6.0 484.6  17.9 0.14 0.9 1.40 0.7
3f 6.33 198.9  6.7 530.0  17.9 0.39 0.7 >5 0.9
4f 4.72 203.6  8.4 564.3  23.2 0.011 0.7 0.073 1.0
5f 7.01 271.8  11.9 601.8  28.4 0.018 1.2 0.15 0.9
6f 4.58 286.0  12.4 565.0  27.1 0.0048 0.9 0.038 1.1
7f 4.58 263.4  27.6 544.6  40.4 0.084 1.0 0.21 0.8
8 4.58 203.0  21.7 520.1  21.8 na na na na
9 3.20 114.1  1.3 392.9  2.9 1.76 1.8 na na
10 4.35 150.2  1.5 415.1  3.0 1.80 2.1 na na
11 3.13 157.5  1.5 396.4  2.9 1.05 1.5 na na
a clogP calculated using Fieldview version 2.0.2 for Macintosh (Wildman Crippenmodel). b Polar surface area (PSA). c Total surface area (TSA). Both
PSA and TSA values were calculated withMD simulations of 10 ns length (see ESI for details†). d EC50,270s dened as the concentration (mol% carrier
to lipid) needed to obtain 50% chloride eﬄux aer 270 s. e Hill coeﬃcient. f Some of the transport activity observed may be the consequence of H+/
Cl co transport.
Table 3 Hammett substituent constants, s, for moieties found in compounds 1
11 (ref. 46)
Compound Substituent smeta spara
1 H 0.00 0.00
2 F 0.34 0.06
3 Cl 0.37 0.23
4 CN 0.66
5 CF3 0.54
6 NO2 0.78
7 NO2 0.71
8 NO2
9 CN 0.66
10 CF3 0.54
11 NO2 0.78
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View Article Onlinecompounds capable of facilitating the transmembrane
transport of anions. Parent compound 1 shows poor transport
activity. Halogenation of the phenyl core in the 4- andFig. 5 Chloride eﬄux promoted by a DMSO solution of compounds 6 at various
loadings from unilamellar POPC vesicles loaded with 488mMNaCl buﬀered to pH
7.2 with 5 mM sodium phosphate salts. The vesicles were dispersed in 488 mM
NaNO3 buﬀered to pH 7.2 with 5 mM sodium phosphate salts. At the end of the
experiment detergent was added to lyse the vesicles and calibrate the ISE to
100% chloride eﬄux. Each point represents an average of three trials. DMSO was
used as a control.
108 | Chem. Sci., 2013, 4, 103 1175-positions improved transporter activity, but to a less dramatic
extent than the addition of electron withdrawing functionalities
to the 4-position of the peripheral phenyl groups. In these
instances transporter activity was observed to increase with
increasing electron withdrawing strength of the substituents
(represented by the Hammett constants shown in Table 3); H < F
 Cl < CF3 < CN < NO2. This trend is consequently reected in
the binding constants, with transport inactive receptor 1
exhibiting relatively low binding constants with chloride and
bicarbonate (43 M1 and 1270 M1 respectively), in comparison
to the most active transporter 6, (78 M1 and 3770 M1
respectively), reecting the strong electron withdrawing eﬀect
of the nitro functionality. Indeed, para-nitro functionalised
compound 6 displays very high transport activity, facilitating
chloride eﬄux at receptor : lipid ratios as low as 1 : 1 000 000
(Fig. 5). To the best of our knowledge we believe that this is the
lowest loading level of transporter observed that can facilitate
transport to date.
We have also examined the eﬀect of varying substituent posi-
tion on the peripheral phenyl rings (compounds 6, 7, and 8). The
nitro functionality is most electron withdrawing in the ortho- and
para-positions.52 para-Nitro functionalised compound 6 shows
greater transporter activity than meta-nitro functionalised
compound 7. The ortho-nitro functionalised compound 8 displays
poor transport activity, likely a consequence of the involvement of
the nitro group in intramolecular hydrogen bonding and also
sterically hindering the binding site.17b This is reected in the
stability constants for compound 8 with chloride and bicarbonate
(<10 M1 and 826 M1 respectively) which are signicantly lower
than those observed for compounds 6 and 7.
The transport activity of the monourea analogues of the three
most active bisurea compounds (4, 5 and 6) were tested using
vesicles containing sodium chloride (488 mM with 5 mM phos-
phate buﬀer at pH 7.2) and suspended in a solution of sodium
nitrate (488 mM with 5 mM phosphate buﬀer at pH 7.2).
Compounds 9, 10 and 11 were tested at loadings of 2 mol% (with
respect to lipid), and the results compared to the eﬄux measured
upon addition of compounds 4, 5 and 6 at loadings of 1 mol%
(with respect to lipid). This ensured that the concentration of ureaThis journal is ª The Royal Society of Chemistry 2013
Fig. 6 Chloride eﬄux promoted by a DMSO solution of monourea compounds
9 11 (2 mol% carrier to lipid) and their analogous bisureas 4 6 (1 mol% carrier to
lipid) from unilamellar POPC vesicles loadedwith 488mMNaCl buﬀered to pH 7.2
with 5 mM sodium phosphate salts. The vesicles were dispersed in 488 mM
NaNO3 buﬀered to pH 7.2 with 5 mM sodium phosphate salts. At the end of the
experiment detergent was added to lyse the vesicles and calibrate the ISE to
100% chloride eﬄux. Each point represents an average of three trials.
Fig. 7 Chloride eﬄux promoted by a DMSO solution of compound 4 (2 mol%
carrier to lipid) from unilamellar POPC vesicles loadedwith either; (i) 451mMNaCl
buﬀered to pH 7.2 with 20 mM sodium phosphate salts and dispersed in 150 mM
Na2SO4 buﬀered to pH 7.2 with 20 mM sodium phosphate salts, or (ii) 451
mMNaCl buﬀered to pH 4.0 with 20mM sodium citrate salts and dispersed in 150
mM Na2SO4 buﬀered to pH 4.0 with 20 mM sodium citrate salts. At t ¼ 120 s a
solution of either sodium fumarate (top) or sodium maleate (bottom) was added
such that the external concentration of carboxylate was 40 mM. At the end of the
experiment, detergent was added to lyse the vesicles and calibrate the ISE to
100% chloride eﬄux. Each point represents an average of three trials. DMSO was
used as a control.
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View Article Onlinegroups was the same. The results (Fig. 6) show that the bisurea
compounds are more active than their monourea analogues.Carboxylate transport
Recently, interest has grown in the construction of molecules
capable of discriminating between small isomeric dicarboxy-
lates.53 Several examples of bisurea compounds with structuralThis journal is ª The Royal Society of Chemistry 2013similarity to compounds 1–8, have been shown to selectively
bind carboxylates.54 Owing to this similarity, we postulated that
out most active transporters (4, 5 and 6) might be able to
facilitate the transmembrane transport of carboxylate anions.
The transmembrane transport of carboxylates is biologically
important; failure of glutamate transporters is linked neuro-
degenerative disorders including Alzheimer’s and Hunting-
don’s disease,55 whilst disruption of oxalate transport can result
in renal disorders.56
We decided to focus on the transmembrane transport of
fumarate and its stereoisomer, maleate. Fumarate has biolog-
ical importance as a key intermediate in the citric acid cycle.57
Carboxylate transport was examined using vesicles containing
sodium chloride buﬀered to pH 7.2, suspended in a solution of
sodium sulphate buﬀered at pH 7.2. Compounds 4, 5 and 6were
added as solutions in DMSO (2 mol% with respect to lipid).
Aer two minutes a sodiummaleate or sodium fumarate ‘pulse’
was added such that the external concentration of the
carboxylate was 40 mM. At pH 7.2 signicant additionalChem. Sci., 2013, 4, 103 117 | 109
Table 4 IC50 values (mM) of cytotoxic compounds 2, 5 and 8 on GLC4, A549 and
SW480 cancerous cell lines
GLC4 A549 SW480
2 8.0  1.1 10.8  0.7 10.6  0.7
5 5.2  0.1 6.0  0.3 11.1  2.0
8 5.0  1.2 9.2  2.2 3.3  1.2
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View Article Onlinechloride eﬄux was observed on addition of a sodium maleate
‘pulse’ with all three compounds, whilst no signicant
enhancement in chloride eﬄux was seen with the sodium
fumarate ‘pulse’. The experiment was repeated at pH 4.0,
whereupon an enhancement in chloride eﬄux was observed
upon addition of both maleate and fumarate pulses (Fig. 7
shows compound 4 as a representative example).
We have already shown that pre-pulse chloride eﬄux is the
consequence of HCl symport and not sulfate transport or NaCl
symport. We can rationalise the pH dependant nature of the
transport by considering the pKa values for maleate (pKa1 ¼
1.92, pKa2 ¼ 6.23) and fumarate (pKa1 ¼ 3.02, pKa2 ¼ 4.38).52
Thus, at pH 7.2 a higher proportion of maleate exists as the
monoanion, whilst fumarate will predominantly exist as the
dianion. Dianions are more hydrophilic than their mono-
anionic counterparts and will consequently be more diﬃcult to
transport.43 Hence, at pH 7.2 we observe an increase in chloride
transport upon addition of maleate, but little enhancement
upon addition of a fumarate. At pH 4.0 the monoionic forms of
both maleate and fumarate will predominate, and an increase
in chloride eﬄux was observed upon addition of both maleate
and fumarate, corresponding to chloride/carboxylate exchange.
In summary, we have observed that ortho-phenylenediamine-
based bisureas functionalised with electron withdrawing
substituents are potent ion transporters, facilitating chloride/
nitrate and chloride/bicarbonate antiport. In some instances we
have observed carboxylate/chloride antiport and HCl symport.
We have demonstrated that these compounds operate via a
mobile carrier mechanism and that sulphate transport and
metal/chloride symport processes are not facilitated.Cell based assays
The potent anion transport activity of some members of the
series prompted examination of the in vitro cytotoxicity towards
a range of cancerous cell lines. A single point MTT cell viabilityFig. 8 Cell viability after 48 h of compound treatment measured by MTT assay.
Single point screening of compounds 1 8 (10 mM) on a range of cancer cell lines,
from left to right, GLC4, A549, SW480, A375 and CAL27.
110 | Chem. Sci., 2013, 4, 103 117assay was performed with compounds 1–8 (10 mM) on a selec-
tion of cancer cell lines of diverse origin (human small-cell lung
carcinoma GLC4, human alveolar adenocarcinoma A549,
human colon adenocarcinoma SW480, human melanoma A375
and human oral adenosquamos carcinoma CAL27). Cell
viability was assessed 48 hours aer exposure to each of the
compounds. Fig. 8 shows that compounds 2, 5 and 8 displayFig. 9 Acridine Orange staining of melanoma A375 cells after 1 hour exposure
to compounds 1 8 (50 mM): (Ct) control (untreated cells). Cells with cytoplasmic
granular orange ﬂuorescence (Ct, 1, 4 and 8); cells with a signiﬁcant reduction in
cytoplasmic orange ﬂuorescence (2 and 3); cells with complete disappearance of
cytoplasmic orange ﬂuorescence (5, 6 and 7).
This journal is ª The Royal Society of Chemistry 2013
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View Article Onlinesignicant cytotoxicity towards the GLC4, A549, SW480 and
A375 cell lines. In comparison compounds 3, 6 and 7 are less
toxic, whilst compounds 1 and 4 are the least toxic in the series
(Fig. 8).
Dose–response curve experiments were performed and IC50
values (Inhibitory Concentration of 50% of cell population)
were calculated for the most cytotoxic compounds (uorinated
compounds 2 and 5, and nitro functionalised compound 8) in
the most sensitive cancerous cell lines (Table 4). These results
corroborate the potency of these cytotoxic receptors, showing
IC50 values around 10 mM in GLC4 cells.Fig. 10 Hoechst 33342 staining of A375 cells after 48 hours exposure to
compounds 1 8 (10 mMor 10 mM (a) and 50 mM (b)): (Ct) control (untreated cells).
Cells with typical nuclear morphology (Ct, 1, 3, 4 and 7), cells with nuclear
condensation and apoptotic bodies (2a, 2b, 5a, 5b, 6, 8a, 8b).
This journal is ª The Royal Society of Chemistry 2013We have previously reported that uorination is an eﬀective
strategy for the production of compounds that can function as
cytotoxic agents in cancerous cell lines.15,44 In contrast, the
nitrophenyl group is a known toxicophore.58 The disruption of
intracellular pH (pHi) has been suggested as a strategy for
cancer treatment.59 Modulation of pHi is essential for control of
the cell cycle (amongst other cellular processes) and is regulated
by several mechanisms, including Na+/H+ co-transport,
Cl/HCO3
 antiport, Na+/HCO3
 symport and H+ uniport.60 To
determine if the observed cytotoxicity was caused by sustained
changes in pHi compounds 1–8were studied in A375 melanoma
cells stained with acridine orange (AO) (Fig. 9). Upon proton-
ation this cell-permeable dye displays an orange uorescence
and accumulates within acidic intracellular compartments.
Green uorescence is observed under the more basic conditions
of the cystol.61 Cells in basal conditions were stained with AO
and showed typical granular orange uorescence, correspond-
ing to cellular acidic compartments such as lysosomes (Fig. 9
Ct). A complete loss of orange uorescence was observed on
exposure to compounds 5, 6 and 7 and a signicant reduction in
orange uorescence was observed with compounds 2 and 3.
This corresponds to an increase in the pH of the intracellular
organelles, achieved through acidication of the cytoplasm.
Granular orange uorescence was retained with compounds 1,
4 and 8, indicating that exposure to these compounds did not
facilitate changes in pHi. This nding, combined with the
inactivity of compound 8 in the vesicle based ion transport
assays, suggests that the cytotoxicity in this instance is the
result of a mechanism other than transmembrane ion
transport.58
Cancer cell death can be induced by sustained changes in
pHi.62 Molecules capable of facilitating HCl symport and
Cl/HCO3
 antiport have been shown to induce apoptosis by
facilitating ion transport processes that lower pHi.15,44,63 All of
the compounds that facilitated a reduction in pHi function as
Cl/NO3
 and Cl/HCO3
 antiport agents in vesicle based
assays. In addition, the most active transporter (compound 6)
has been shown to facilitate HCl co-transport. The biological
activity observed in the AO assay could therefore be the direct
result of the transmembrane transport of HCl or bicarbonate, or
the result of ion transport coupled to the uniport of chloride.64
Apoptosis is a form of programmed cell death that facilitates
the removal of damaged cells without causing inammation
and can be induced by sustained changes in pHi. Nuclear
condensation, fragmentation and the formation of apoptotic
bodies are characteristic of this type of cell death.65 The type of
cell death induced by compounds 1–8 was examined using
Hoechst 33342 staining in A375 cells. Hoechst 33342 is a uo-
rescent nuclear dye, permitting changes in nuclear morphology
to be monitored. In Fig. 10 untreated A375 cells have typical
rounded nuclei (Ct). Following treatment with the compounds
(10 mM for 48 hours), the most cytotoxic compounds 2, 5 and 8
showed nuclear condensation (2a, 5a, 8a), and at 50 mM the
formation of apoptotic bodies was observed, conrming that
these compounds induce apoptotic cell death (2b, 5b and 8b).
In summary, compounds 2, 3, 5, 6, 7 and 8 have been shown
to be toxic in a range of cancer cell lines. With the exception ofChem. Sci., 2013, 4, 103 117 | 111
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View Article Onlinecompound 8, all of the cytotoxic compounds were found to
facilitate Cl/NO3
 and Cl/HCO3
 antiport in vesicle based ion
transport assays. In an AO assay compounds 2, 3, 5, 6 and 7were
found to alter pHi in A375 cells and the formation of apoptotic
bodies was clearly observed with the most cytotoxic compounds
(2, 5 and 8) using Hoechst 33342 staining in A375 cells.
Compounds 2 and 5 facilitated apoptotic cell death in A375
cells, likely through sustained changes in pHi as a consequence
of in vitro ion transport. In contrast, compound 8 induced
apoptotic cell death but organelle deacidication was not
observed in the AO assay. The cytotoxicity of this compound
thus appears to be unrelated to its ion transport activity
(compound 8 was found to be inactive in vesicle based ion
transport assays) and may therefore be the result of an alter-
native mechanism.58 Compound 5 was shown to reduce the
viability of the cell lines to a greater extent than compound 6
whilst compound 6 is themost eﬀective anion transporter of the
two compounds. This could be due to diﬀerences between the
model membrane used for the vesicle studies and the biological
membranes present in the cells. We are continuing to study the
eﬀects of these compounds on cells.Molecular dynamics simulations on POPC bilayer model
The ability of 5 and 6 to permeate a POPC bilayer model, being
the rst step towards the anion transport, was also investigated
by molecular dynamics (MD) simulations using the AMBER12
soware.66 These mobile carriers were selected taking into
account that, among the ortho-phenylendimine-based bisureas,
5with two p-CF3 substituents is signicantly the more lipophilic
one, while 6 functionalized with two p-NO2 withdrawing elec-
tron substituents is the most active Cl/HCO3
 anion
exchanger.
These modelling studies were carried out with 5$Cl, 6$Cl
and 5$HCO3
 complexes and using a bilayer system (square in
the xy plane), composed of 128 POPC lipids and 6500 TIP3P
water molecules,67 as model of a POPC vesicle. The compounds
5 and 6 and bicarbonate anion were described with GAFF68 and
RESP atomic charges (see ESI for details†), while the LIPID11Fig. 11 Molecular mechanics lowest energy structures of 5 Cl (top) and
5 HCO3 (bottom) complexes, with N Cl distances ranging from 3.367 to
3.378 A˚, and N O distances ranging from 2.748 to 2.873 A˚.
112 | Chem. Sci., 2013, 4, 103 117force eld parameters69 were used for the lipid molecules. The
chloride anion and sodium counterion with respective net
charges of 1 and +1 were described with van der Waals
parameters developed for the TIP3P water model.70 TheFig. 12 Relative positions of 5, 6, Cl and HCO3 species deﬁned by the
distances between their centre of mass and the closest water lipid interface,
which results from the average position of the corresponding phosphorus atoms
in the z coordinate. Initial complexes per plot: 5 Cl top; 5 HCO3 middle; and
6 Cl bottom. The following line colour scheme was used: light blue for R1 and
dark blue for R2 of 5; purple for R1 and magenta for R2 of 6; green for Cl ; and
red for HCO3 . The water lipid interface is represented as a black line at z ¼ 0 A˚.
Only the position of the anion along the replicate R1 is represented.
This journal is ª The Royal Society of Chemistry 2013
Fig. 13 Passive diﬀusion of 5 Cl along the POPC bilayer showing the interaction of 5 with the phospholipid heads with three sequential snapshots taken from a
representative MD replicate (R1). The receptor and phosphorus atoms are drawn in space ﬁlling fashion with hydrogen atoms in white, oxygen atoms in red, nitrogen
atoms in light blue and carbon atoms in grey (receptor) or wheat (phospholipids) colour. The van der Waals radius of P was arbitrarily set to 1.2 A˚. The water slabs and
the second monolayer of phospholipids were omitted for clarity.
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View Article Onlinemembrane simulations were performed under periodic
boundary conditions in a NPT ensemble at 303 K with a surface
tension of 17 dyn cm1 and an 8 A˚ cut-oﬀ for van der Waals and
non-bonded electrostatic interactions following the protocol
detailed in ESI.†
The starting binding arrangements of the anionic complexes
were determined in gas phase by quenchedmolecular dynamics
as stated in ESI.† In the lowest energy structures of the halide
complexes, the two-bisurea binding sites adopt a syn congu-
ration, establishing four N–H/Cl hydrogen bonds. In the
5$HCO3
 complex, three N–H binding sites form three N–H/O
hydrogen bonds with an oxygen atom from the –CO2
 group
while the remaining N–H binding site is involved in a N–H/O
single hydrogen bond with the other oxygen atom from this
group. These two binding scenarios are illustrated in Fig. 11
with the structures of 5$Cl and 5$HCO3
 complexes, along
with hydrogen bonds lengths.
Aerwards, 5$Cl, 6$Cl and 5$HCO3
 complexes were
initially positioned in the water slab of a pre-equilibrated
POPC bilayer at distances larger than 8 A˚ away from the water–
lipid interface (see Fig. S95 in ESI†) and subject to a production
run of 80 ns simulation length, preceded by a multi-stageFig. 14 Passive diﬀusion of 6 Cl along POPC bilayer illustrated with three sequen
Fig. 13.
This journal is ª The Royal Society of Chemistry 2013equilibration process (see ESI†). Two independent replicates
(R1 and R2) were performed for each system using
diﬀerent initial velocities and comparable sequences of events
were observed as described below. The chloride and bicar-
bonate anions are promptly solvated by water molecules and
released in the water phase before either 5 or 6 reach the
water–lipid interface, which occurs within the rst 20 ns of the
production runs as depicted in Fig. 12 for all anion complexes.
This rst insight indicates that in the water phase, 5 displays
equivalent binding behaviours towards both anions and
henceforth the simulations carried out with 5$Cl and
5$HCO3
 are analysed together. Aerwards, the free receptors
interact with the membrane interface in a comparable fashion.
Indeed, 5 is able to either permeate the membrane or to
remain at the interface during almost of the subsequent
simulation time, as also evident in Fig. 12 (top and middle
plots). Surprisingly, the two replicates performed with 6$Cl
reveal that this less lipophilic receptor (see Table 2) permeates
the membrane more easily, which can be correlated with the
population of N–H/O]P hydrogen bonds established
between the amide binding sites and phosphate head groups,
as discussed below.tial snapshots of a representative MD replicate (R2). Remaining details as given in
Chem. Sci., 2013, 4, 103 117 | 113
Fig. 15 Insights into N H O]P hydrogen bonding interactions between
phospholipids and transporters 5 (left) and 6 (right).
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View Article OnlineThe events’ sequences associated with the passive diﬀusion
of 5 and 6 towards POPC, described above, are illustrated in
Fig. 13 and 14 with three consecutive snapshots taken from the
MD simulations of 5$Cl and 6$Cl complexes, respectively.
Fig. 13 and 14 show that the rst interaction of 5 and 6 with
membrane occurs through the p-CF3 or p-NO2 groups from an
ortho-phenyldiamine substituent. Subsequently, regardless of
the relative position of the receptors to the interface, both p-
substituents of 5 are preferentially located between the lipids
chains, pointing to the bilayer core, while the ortho-phenyldi-
amine head with the two syn urea binding units are closer to the
water–lipid interface, thus able to form strong hydrogen
bonding interactions with the phosphate head groups as shown
in Fig. 15 (le). This is particularly evident in replicates R2 and
R1 of complexes 5$Cl and 5$HCO3
, respectively, where the
receptor mainly remains at the water–lipid interface throughoutTable 5 Average structural parameters area per lipid (A˚2) and bilayer thickness
(A˚) of membrane systems, with the corresponding standard deviationsa
System Area Thickness
Pure membrane
Experimental71 64.30 39.10
Simulated 64.38  0.74 38.28  0.37
Transporters in POPC
5$Cl R1 62.16  0.53 39.34  0.24
R2 61.25  0.49 39.80  0.31
5$HCO3 R1 62.67  0.74 39.30  0.44
R2 61.50  0.77 39.97  0.30
6$Cl R1 62.39  0.40 39.14  0.23
R2 61.79  0.91 39.67  0.61
a The sampling time for the pure membrane was 40 ns, while the
remaining systems were analysed during the nal 10 ns of the MD
simulation time.
114 | Chem. Sci., 2013, 4, 103 117the course of the MD simulation (see Fig. 12, top and middle
plots, above and Fig. S96,† le and right top plots). In contrast,
the slightly lighter receptor 6 (mol. wt 436.11 of 6 vs. 482.12 of 5)
permeates the phospholipid bilayer more deeply during the
simulation time (see Fig. 12, bottom) with a non-specic spatial
orientation consistent with the existence of sporadic N–H/O]
P hydrogen bonds. These interactions generally occur via a
single urea binding unit, as depicted in Fig. 15 (right), and are
observed during both MD simulations replicates of 6$Cl (see
Fig. S96,† bottom), in spite of this receptor higher propensity to
establish hydrogen bonding interactions (see Table 3). In other
words, these results seem to indicate that N–H binding sites of 6
are available to bind the anions and consequently to promote
their transmembrane transport, in agreement with the chloride
eﬄux experimental data.
In order to ascertain the impact of 5 and 6 on the structural
properties of the POPC bilayer, the aforementioned simulations
were preceded by a simulation of the free membrane under the
same computational conditions. The following structural
membrane parameters, area per lipid, bilayer thickness, elec-
tronic density prole and order parameters were evaluated and
compared with the corresponding experimental data and with
those found for the last 10 ns of MD replicates of 5$Cl, 6$Cl
and 5$HCO3
 complexes. The rst two parameters’ values are
listed in Table 5, whereas the corresponding electronic density
proles and order parameters are plotted in Fig. S100 to S105.†
As would be expected, the average values of the area per lipid
(64.38 A˚2) and bilayer thickness (38.28 A˚) calculated for the free
membrane are similar to those recently obtained by neutron
scattering (64.30 A˚2 and 39.10 A˚),71 and as reported when a
POPC bilayer with 128 lipids is simulated using the aforemen-
tioned simulation conditions.69 The interaction of 5 and 6 with
the membrane produces a slight decrease in the area per lipid
(<4.8%) and, consequently, a slight increase in the bilayer
thickness (<2.2%), indicating that the inuence of both recep-
tors on these two structural parameters is small. The order
parameters for saturated (sn-1) and unsaturated (sn-2) POPC
lipid chains of the free membrane (see Fig. S99†) follow the ones
previously found with LIPID11.69 Similar proles were obtained
for the membrane simulations carried out with 5 and 6 (see
Fig. S103 to S105†), suggesting that the order parameters are
unaﬀected by the presence of the receptors. In fact, the single
exception was found for the sn-2 tails of POPC in replicate R2 of
5$Cl in which the receptor is preferentially located near of the
water–lipid interface. Furthermore, the electronic density
proles for all simulated systems show that the bilayer structure
is preserved without apparent interdigitation between the
phospholipid tails as shown in Fig. S100 to S102, and further
discussed in ESI.† In addition, the electronic density proles for
the receptors are consistent with their relative position to the
water–lipid interface throughout the simulation time, as rep-
resented in Fig. 12.
The energy proles associated with Cl and HCO3
 facili-
tated transport across a phospholipid bilayer by ortho-phenyl-
enediamine-based bisureas (namely 4, 5 and 6), as well as the
theoretical investigation of Cl/HCO3
 exchange mechanisms
in more complex membrane systems (models of vesicles) andThis journal is ª The Royal Society of Chemistry 2013
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View Article Onlinemore computationally demanding, are currently in progress.
However, the studies reported here have unequivocally shown
that two of the most promising receptors are able to permeate
the membrane, having a low impact in its structure, being
capable of mediating anion transport as mobile carriers.Conclusions
We have demonstrated that the ortho-phenylenebisurea motif is
a new scaﬀold for the construction of transmembrane ion
transporters that function by an anion antiport and in some
cases a HCl co-transport mechanism. Addition of electron
withdrawing groups to either the central core or the peripheral
phenyl groups yielded potent anion transporters for the trans-
membrane transport of chloride, nitrate and bicarbonate with
transport observed at receptor: lipid concentration ratios as low
as 1 : 1 000 000. Compounds 2, 3, 5, 6 and 7 were found to be
cytotoxic in a range of cancer cell lines. AO assays conrmed
that these compounds can facilitate a reduction in pHi and the
two most cytotoxic compounds (2 and 5) were found to induce
apoptosis in A375 cells. We have also demonstrated that our
most active transporters (4, 5 and 6) can facilitate the trans-
membrane transport of carboxylate species. We are continuing
to study the transport of biologically relevant carboxylates. The
results of these studies will be reported in due course. The MD
results have demonstrated, at the atomic level, the ability of 5
and 6 to permeate the membrane while having a reduced
inuence on its properties.Acknowledgements
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